4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-062464
Chief Financial Officer bought 250 shares at $7.81 ($1,953)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2017-11-22 | Purchase | +250 | $7.81 | $1,953 | 15,697 | D |
| Open-market purchases · 250 sh · avg $7.81 · $1,953 | |||||||
Loading xslF345X03/doc4.xml…